Development and Validation of the PREVES-HOR Questionnaire: A Patient-Reported Measure of Hormone Therapy-Related Quality of Life in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy.

Di Lorenzo G, Verde A, Scafuri L, Baio R, Grillone F, Passaro F, Crocetto F, Bruzzese D, Ferraioli A, Monteleone E, Rossetti S, Montanaro V, Metta G, Prata F, Ruffo A, Romeo G, Balsamo R, Calogero A, Strianese O, Maiorino F, Tartarone A, Ferro M, Bove P, Donnarumma A, Verze P, Papalia R, Perdonà S, Riccio V, Costa E, Scocca C, Aliberti A, Cappuccio F, Buonerba C

Open source

DOI
10.1159/000548317
Published
2026
Container
Oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1159/000548317,
  title = {Development and Validation of the PREVES-HOR Questionnaire: A Patient-Reported Measure of Hormone Therapy-Related Quality of Life in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy.},
  author = {Di Lorenzo G and Verde A and Scafuri L and Baio R and Grillone F and Passaro F and Crocetto F and Bruzzese D and Ferraioli A and Monteleone E and Rossetti S and Montanaro V and Metta G and Prata F and Ruffo A and Romeo G and Balsamo R and Calogero A and Strianese O and Maiorino F and Tartarone A and Ferro M and Bove P and Donnarumma A and Verze P and Papalia R and Perdonà S and Riccio V and Costa E and Scocca C and Aliberti A and Cappuccio F and Buonerba C},
  year = {2026},
  journal = {Oncology},
  doi = {10.1159/000548317},
  url = {https://doi.org/10.1159/000548317}
}

RIS

TY  - JOUR
TI  - Development and Validation of the PREVES-HOR Questionnaire: A Patient-Reported Measure of Hormone Therapy-Related Quality of Life in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy.
AU  - Di Lorenzo G
AU  - Verde A
AU  - Scafuri L
AU  - Baio R
AU  - Grillone F
AU  - Passaro F
AU  - Crocetto F
AU  - Bruzzese D
AU  - Ferraioli A
AU  - Monteleone E
AU  - Rossetti S
AU  - Montanaro V
AU  - Metta G
AU  - Prata F
AU  - Ruffo A
AU  - Romeo G
AU  - Balsamo R
AU  - Calogero A
AU  - Strianese O
AU  - Maiorino F
AU  - Tartarone A
AU  - Ferro M
AU  - Bove P
AU  - Donnarumma A
AU  - Verze P
AU  - Papalia R
AU  - Perdonà S
AU  - Riccio V
AU  - Costa E
AU  - Scocca C
AU  - Aliberti A
AU  - Cappuccio F
AU  - Buonerba C
PY  - 2026
JO  - Oncology
DO  - 10.1159/000548317
UR  - https://doi.org/10.1159/000548317
ER  - 

APA

G, D. L., A, V., L, S., R, B., F, G., F, P., F, C., D, B., A, F., E, M., S, R., V, M., G, M., F, P., A, R., G, R., R, B., A, C., O, S., F, M., A, T., M, F., P, B., A, D., P, V., R, P., S, P., V, R., E, C., C, S., A, A., F, C., & C, B. (2026). Development and Validation of the PREVES-HOR Questionnaire: A Patient-Reported Measure of Hormone Therapy-Related Quality of Life in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy.. Oncology. https://doi.org/10.1159/000548317

Source records